Senior Director, IDMO Site Quality at Cellares

Bridgewater, New Jersey, United States

Cellares Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Pharmaceuticals, Cell TherapyIndustries

Requirements

  • Bachelor's degree in science, engineering, or related field required
  • 10+ years of Quality Management experience within a cGMP environment in the biotech/biopharma industry
  • Minimum of 5 years of senior leadership experience
  • Cell/Gene Therapy and CDMO experience preferred
  • Work effectively with US FDA and other regulatory agencies
  • Substantial knowledge of Quality Systems, GMP, FDA, GAMP, ISO and other applicable standards
  • Proven experience implementing continuous improvement initiatives to drive Quality programs and ensure maximum productivity
  • Ensure Quality systems meet the needs of all internal and external stakeholders with an emphasis on process, quality, productivity, budget control, and profitability
  • Past experience developing, implementing, and monitoring Quality programs, policies and procedures to ensure compliance with GMP standards, corporate policies, FDA, EMA and other regulatory body regulations and guidelines
  • Serve as the point person with industry partners regarding product quality matters, customer satisfaction levels, and regulatory authority interaction
  • Must be able to manage shifting priorities to meet critical deadlines in a fast paced and dynamic, growing environment, while providing clear direction to team members
  • History of developing and building cohesive, high performing teams with a strong sense of mission, providing training and mentoring to build sufficient management depth throughout the organization

Responsibilities

  • Lead, direct, coach, and develop an effective QA and QC team responsible for daily clinical and commercial production of autologous and allogeneic cell therapy products, while ensuring safe and compliant operations according to cGMP requirements
  • Provide technical and managerial leadership by effectively interfacing and collaborating with key stakeholders and functions across the organization to successfully manufacture and disposition products to patients in a timely manner
  • Oversee the hiring, development, and performance management of staff within QA and QC
  • Develop a Quality Culture and compliance related manufacturing and process controls to improve quality systems
  • Establish critical KPIs, monitor progress and keep critical stakeholders informed of progress
  • Lead and actively participate in all regulatory and internal audits of the facility
  • Work closely with other functional areas to develop and execute against the strategic plan for the manufacturing site
  • Establish key stakeholder relationships with internal and external stakeholders

Skills

cGMP
QA
QC
QMS
Cell Therapy
Manufacturing
Regulatory Compliance
GMP Operations
Quality Assurance
Quality Control

Cellares

Develops and manufactures cell therapies efficiently

About Cellares

Cellares develops and manufactures cell therapies in the biotechnology sector, operating as an Integrated Development and Manufacturing Organization (IDMO). Its proprietary "Smart Factory" technology features an automated single-use cartridge system, which increases productivity and reduces costs and process failures compared to traditional methods. The company serves a range of clients, including pharmaceutical companies, and aims to provide efficient and cost-effective manufacturing services for cell therapies. Cellares stands out by combining development and manufacturing processes under one roof, making it a competitive option in the industry.

South San Francisco, CaliforniaHeadquarters
2019Year Founded
$345.3MTotal Funding
SERIES_CCompany Stage
Industrial & Manufacturing, BiotechnologyIndustries
201-500Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
401(k) Company Match
Stock Options

Risks

Emerging biotech startups threaten Cellares' market share with similar solutions.
Potential regulatory delays could impact scaling of new automated systems like Cell Q.
Supply chain vulnerabilities may disrupt production timelines for Cell Shuttle and Cell Q.

Differentiation

Cellares' Cell Shuttle offers 10x scalability over manual cell therapy manufacturing.
The Smart Factory technology integrates development and manufacturing, unlike traditional CDMOs.
Cell Q automates QC processes, addressing bottlenecks in cell therapy quality control.

Upsides

Partnership with Sony enhances precision in cell therapy manufacturing processes.
Strategic partnership with Bristol Myers Squibb provides financial boost and validation.
Ossama Eissa's appointment as COO accelerates global expansion and operational capabilities.

Land your dream remote job 3x faster with AI